AbCellera Biologics (ABCL) EBITDA (2020 - 2026)
AbCellera Biologics (ABCL) reported EBITDA of -$55.75 million for Q2 2026, compared with -$44.06 million a year earlier.
Powered by 
Analysis
AbCellera Biologics (ABCL) EBITDA (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, AbCellera Biologics' EBITDA came in at -$199.97 million; for FY2025, it came in at -$194.93 million.
- By year, EBITDA came in at -$223.92 million in FY2024, -$212.77 million in FY2023, $244.4 million in FY2022 (+11.7%) and $218.88 million in FY2021 (+36.1%).
- Five-year quarterly EBITDA spans a low of -$71.04 million in Q3 2025 and a high of $228.96 million in Q1 2022.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$50.68 million (Q1 2026), -$22.5 million (Q4 2025) and -$71.04 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 13.33 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 7.37 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 7.05 Bn |
| 10 | AbCellera Biologics | 3.83 Bn | 3.29 Bn | - | -55.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -55.75 Mn |
| Mar 31, 2026 | -50.68 Mn |
| Dec 31, 2025 | -22.50 Mn |
| Sep 30, 2025 | -71.04 Mn |
| Jun 30, 2025 | -44.06 Mn |
| Mar 31, 2025 | -57.33 Mn |
| Dec 31, 2024 | -60.19 Mn |
| Sep 30, 2024 | -56.78 Mn |
| Jun 30, 2024 | -56.98 Mn |
| Mar 31, 2024 | -50.01 Mn |
| Dec 31, 2023 | -58.50 Mn |
| Sep 30, 2023 | -49.12 Mn |
| Jun 30, 2023 | -45.73 Mn |
| Mar 31, 2023 | -59.32 Mn |
| Dec 31, 2022 | -23.94 Mn |
| Sep 30, 2022 | 42.87 Mn |
| Jun 30, 2022 | -3.49 Mn |
| Mar 31, 2022 | 228.96 Mn |
| Dec 31, 2021 | 85.49 Mn |
| Sep 30, 2021 | -24.39 Mn |
API Access
AbCellera Biologics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=ABCL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "ABCL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=ABCL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();